ERBB2 and neoplasm: In ER+, ERBB2 non-amplified ILC, oncERBB2mut status was prognostic of 10-year OS independently of LN status, tumor grade, and size (HR 3.65, 95% CI 1.21–11.00; p = 0.021, see Fig. 3).